Abstract
It has been shown that lymphocytes isolated from the peripheral blood of patients with chronic lymphocytic leukaemia do not modify the mustard group of chlorambucil, as has been demonstrated previously in Yoshida ascites cells. However, lymphocytes from patients with an unsatisfactory clinical course or poor response to treatment were able to modify the aromatic region of the drug molecule; little change occurred in the aromatic absorption of intracellular chlorambucil in patients who responded to treatment. This simple test may provide a rapid assessment of a patient's potential response to chemotherapy.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Harrap K. R., Hill B. T. The selectivity of action of alkylating agents and drug resistance. 3. The uptake and degradation of alkylating drugs by Yoshida ascites sarcoma cells in vitro. Biochem Pharmacol. 1970 Jan;19(1):209–217. doi: 10.1016/0006-2952(70)90341-2. [DOI] [PubMed] [Google Scholar]
- Lawler S. D., Lele K. P., Pentycross C. R. A simple in-vitro test for assessing the sensitivity of lymphocytes to chlorambucil. Br J Cancer. 1971 Sep;25(3):493–500. doi: 10.1038/bjc.1971.62. [DOI] [PMC free article] [PubMed] [Google Scholar]